Millions more Brits could get weight-loss jabs on NHS to prevent heart attack and stroke – are you e...

Semaglutide, known as Wegovy, approved for preventing heart attacks and strokes in overweight individuals with cardiovascular disease. It reduces major cardiovascular events by 20%, aids weight management, and is under review for NHS use. Novo Nordisk faces supply constraints amidst high demand.